Received Dec 1, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLU3 | INFLUENZA (SEASONAL) (FLUZONE) | SANOFI PASTEUR | UNK | — | OT |
having a rash; Initial information received on 21-Nov-2025 regarding an unsolicited valid non-serious case received from a patient This case involves an unknown age female patient who experienced having a rash after receiving Influenza Usp Trival A-B Subvirion No Preservative Vaccine [Fluzone]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received an unknown dose of suspect Influenza Usp Trival A-B Subvirion No Preservative Vaccine, Suspension for injection (lot number, expiry date and strength not reported) via unknown route in unknown administration site for Immunization. Information on the batch number was requested corresponding to the one at time of event occurrence. On an unknown date the patient having a rash (rash) (unknown latency). It was reported "A Consumer Wanting To Know If The Flublok Is The Same As The Fluzone By Sanofi; Caller Wanting To Know What Are The Differences; And Wanting To Know If Flublok Is An Mrna Vaccine.The Consumer Reported That They Had Reactions With Some Fluzone Injections In The Past; That The Reaction Are Described As Sensitivities To Flu Vaccines With Having A Rash; That The Rash Would Appear 3 To 5 Days After The Injections". Action taken was not applicable. It was not reported if the patient received a corrective treatment for the event. At time of reporting, the outcome was Recovered / Resolved on an unknown date for the event.